glycerophosphoethanolamine has been researched along with dactolisib in 1 studies
Studies (glycerophosphoethanolamine) | Trials (glycerophosphoethanolamine) | Recent Studies (post-2010) (glycerophosphoethanolamine) | Studies (dactolisib) | Trials (dactolisib) | Recent Studies (post-2010) (dactolisib) |
---|---|---|---|---|---|
147 | 2 | 35 | 444 | 14 | 405 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bathen, TF; Engebråten, O; Esmaeili, M; Gribbestad, IS; Moestue, SA; Mælandsmo, GM | 1 |
1 other study(ies) available for glycerophosphoethanolamine and dactolisib
Article | Year |
---|---|
Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Ethanolamines; Female; Humans; Imidazoles; Magnetic Resonance Spectroscopy; Mice; Phosphatidylethanolamines; Phosphorus Isotopes; Phosphorylcholine; Quinolines; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2014 |